Literature DB >> 30397330

Nonsurgical management of Peyronie's disease.

Peter Tsambarlis1, Laurence A Levine2.   

Abstract

Peyronie's disease is not a rare disorder, and it can be devastating to the affected man. Although the gold-standard treatment of Peyronie's disease is surgery in the stable phase, nonoperative management is preferred by some men and is the only treatment option in the acute phase of the disease, when surgery is contraindicated. No oral or topical therapy has been shown to be efficacious when administered alone, but some evidence supports their use as part of a combination therapy regimen. Intralesional therapies, particularly collagenase clostridium histolyticum (CCH), have shown promise. Mechanical therapies can provide benefit when applied for prolonged periods of time, improving penile curvature, indentation, and even restoring length. Regardless of the modality chosen, patient counselling is paramount, as recovery of the penis to its predisease state is highly unlikely. Thus, although many options exist for nonsurgical management of Peyronie's disease, surgery remains the best option for men who desire the most reliable and rapid pathway to a functionally straight, erect penis. The goal of nonsurgical therapy should be a scientifically feasible, safe approach to prevent the progression of, or reduce, deformity and improve sexual function.

Entities:  

Mesh:

Year:  2019        PMID: 30397330     DOI: 10.1038/s41585-018-0117-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  5 in total

Review 1.  Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.

Authors:  Ayad Yousif; Caleb Natale; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2021-01-08       Impact factor: 3.092

2.  The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer.

Authors:  Yannick Fabian Diehm; Katharina Marstaller; Anna-Maria Seckler; Martin Reinhold Berger; Michael Zepp; Matthias Martin Gaida; Julia Thomé; Dimitra Kotsougiani-Fischer; Ulrich Kneser; Sebastian Fischer
Journal:  Breast Cancer       Date:  2022-02-07       Impact factor: 4.239

Review 3.  Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

4.  Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis.

Authors:  Dehong Cao; Jinze Li; You Lu; Yin Huang; Bo Chen; Zeyu Chen; Yinzhi Shen; Liangren Liu; Qiang Wei
Journal:  Front Med (Lausanne)       Date:  2022-02-18

Review 5.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.